$300 | Single User
$600 | Site License
$900 | Global License

GlaxoSmithKline Consumer Nigeria PLC (GLAXOSMITH) - Financial and Strategic SWOT Analysis Review
[Report Updated: 28-09-2018]

Published by Global Data: 28 Sep 2018 | 223005 | In Stock
Related Topics: GlaxoSmithKline

Introduction

Summary

GlaxoSmithKline Consumer Nigeria Plc (GlaxoSmithKline Consumer Nigeria), a subsidiary of GlaxoSmithKline Plc, is a healthcare company that research and develops pharmaceuticals, vaccines and consumer healthcare products. The company offers pain relief products, nutritionals, digestive health, oral health and respiratory products, among others. It provides pharmaceutical products for the treatment of asthma, malaria, depression, migraine, diabetes, heart failure, and others. GlaxoSmithKline Consumer Nigeria product such as digestive conditions, and cancer; and vaccines to protect against illnesses such as hepatitis A and B, diphtheria, tetanus, whooping cough, typhoid, influenza and cervical cancer, among others. The company operates through its manufacturing facility in Agbara. GlaxoSmithKline Consumer Nigeria is headquartered in Ikeja, Nigeria.

This comprehensive SWOT profile of GlaxoSmithKline Consumer Nigeria PLC provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of GlaxoSmithKline Consumer Nigeria PLC including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – Analyst’s summarization of the company’s business strategy.

- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Table of Contents
for GlaxoSmithKline Consumer Nigeria PLC (GLAXOSMITH) - Financial and Strategic SWOT Analysis Review [Report Updated: 28-09-2018]

  • Table of Contents

    Section 1 - About the Company

    GlaxoSmithKline Consumer Nigeria PLC - Key Information

    GlaxoSmithKline Consumer Nigeria PLC - Overview

    GlaxoSmithKline Consumer Nigeria PLC - Key Employees

    GlaxoSmithKline Consumer Nigeria PLC - Key Employee Biographies

    GlaxoSmithKline Consumer Nigeria PLC - Key Operational Heads

    GlaxoSmithKline Consumer Nigeria PLC - Major Products and Services

    GlaxoSmithKline Consumer Nigeria PLC - History

    GlaxoSmithKline Consumer Nigeria PLC - Company Statement

    GlaxoSmithKline Consumer Nigeria PLC - Locations And Subsidiaries

    GlaxoSmithKline Consumer Nigeria PLC - Key Manufacturing facilities

    Head Office

    Other Locations & Subsidiaries

    Section 2 - Company Analysis

    GlaxoSmithKline Consumer Nigeria PLC - Business Description

    GlaxoSmithKline Consumer Nigeria PLC - Corporate Strategy

    GlaxoSmithKline Consumer Nigeria PLC - SWOT Analysis

    SWOT Analysis - Overview

    GlaxoSmithKline Consumer Nigeria PLC - Strengths

    GlaxoSmithKline Consumer Nigeria PLC - Weaknesses

    GlaxoSmithKline Consumer Nigeria PLC - Opportunities

    GlaxoSmithKline Consumer Nigeria PLC - Threats

    GlaxoSmithKline Consumer Nigeria PLC - Key Competitors

    Section 3 - Company Financial Performance Charts

    GlaxoSmithKline Consumer Nigeria PLC - Financial Ratios

    Financial Ratios - Capital Market Ratios

    Financial Ratios - Annual Ratios

    Financial Ratios - Interim Ratios

    Financial Ratios - Ratio Charts

    Section 4 - Appendix

    Appendix

    Methodology

    Ratio Definitions

    About GlobalData

    Contact Us

    Disclaimer

    Note*: Some sections may be missing if data is unavailable for the company

List Of Tables
in GlaxoSmithKline Consumer Nigeria PLC (GLAXOSMITH) - Financial and Strategic SWOT Analysis Review [Report Updated: 28-09-2018]

List of Tables


GlaxoSmithKline Consumer Nigeria PLC, Key Information

GlaxoSmithKline Consumer Nigeria PLC, Key Ratios

GlaxoSmithKline Consumer Nigeria PLC, Share Data

GlaxoSmithKline Consumer Nigeria PLC, Major Products and Services

GlaxoSmithKline Consumer Nigeria PLC, History

GlaxoSmithKline Consumer Nigeria PLC, Key Employees

GlaxoSmithKline Consumer Nigeria PLC, Key Employee Biographies

GlaxoSmithKline Consumer Nigeria PLC, Key Operational Heads

GlaxoSmithKline Consumer Nigeria PLC, Other Locations

GlaxoSmithKline Consumer Nigeria PLC, Subsidiaries

GlaxoSmithKline Consumer Nigeria PLC, Key Manufacturing facilities

GlaxoSmithKline Consumer Nigeria PLC, Key Competitors

GlaxoSmithKline Consumer Nigeria PLC, SWOT Analysis

GlaxoSmithKline Consumer Nigeria PLC, Ratios based on current share price

GlaxoSmithKline Consumer Nigeria PLC, Annual Ratios

GlaxoSmithKline Consumer Nigeria PLC, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List Of Figures, Charts and Diagrams
in GlaxoSmithKline Consumer Nigeria PLC (GLAXOSMITH) - Financial and Strategic SWOT Analysis Review [Report Updated: 28-09-2018]

List of Figures


GlaxoSmithKline Consumer Nigeria PLC, Performance Chart

GlaxoSmithKline Consumer Nigeria PLC, Ratio Charts

Additional Details

Publisher

Global Data

Publisher Information

Reference

223005 | GDPH207667FSA

Number of Pages

25

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
GlaxoSmithKline Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
GlaxoSmithKline K.K. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryGlaxoSmithKline K.K. (GSK Japan) a subsidiary of GlaxoSmithKline Plc is a pharmaceutical comp...
10 Mar 2016 by Global Data USD $250 More Info
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryGlaxoSmithKline Pharmaceuticals Limited (GSK India) is a pharmaceutical company that manufact...
04 Mar 2016 by Global Data USD $250 More Info
GlaxoSmithKline Plc (GSK) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryGlaxoSmithKline plc (GSK) is a healthcare company, which focuses on the development, manufact...
04 Mar 2016 by Global Data USD $250 More Info
GlaxoSmithKline Plc (GSK) - Medical Equipment - Deals and Alliances Profile
SummaryGlaxoSmithKline plc (GSK) is a healthcare company, which focuses on the development, manufact...
24 Feb 2016 by Global Data USD $250 More Info
GlaxoSmithKline Consumer Nigeria PLC (GLAXOSMITH) - Financial and Strategic SWOT Analysis Review
SummaryGlaxoSmithKline Consumer Nigeria PLC (GlaxoSmithKline Consumer Nigeria) a subsidiary of Glaxo...
09 Jan 2016 by Global Data USD $300 More Info
GlaxoSmithKline Consumer Nigeria PLC (GLAXOSMITH) - Financial and Strategic SWOT Analysis Review
SummaryGlaxoSmithKline Consumer Nigeria PLC (GlaxoSmithKline Consumer Nigeria) a subsidiary of Glaxo...
08 Nov 2015 by Global Data USD $300 More Info
Physician Views: Is GlaxoSmithKline's BRAF/MEK combo making headway in V600 mutation-positive melanoma patients?
Scope Although the clinical promise of cancer immunotherapies looks poised to see these products gai...
22 Jul 2014 by FirstWord Pharma USD $695 More Info
Physician Views: Assessing the launch of GlaxoSmithKline's Breo Ellipta
Scope It remains early in the launch, but available evidence suggests that GlaxoSmithKline's Breo El...
21 Jan 2014 by FirstWord Pharma USD $695 More Info
Physician Views: Can GlaxoSmithKline strike early with Anoro? / What role will dosing, inhaler type play in uptake of LAMA/LABA combinations for COPD?
ScopeThis year looks set to be one of notable evolution for the US chronic obstructive pulmonary dis...
01 Aug 2013 by FirstWord Pharma USD $695 More Info

This report is published by Global Data

Download Free Report Summary PDF

GlaxoSmithKline Consumer Nigeria PLC (GLAXOSMITH) - Financial and Strategic SWOT Analysis Review [Report Updated: 28-09-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • 360i Research
  • 99Strategy
  • Allied Market Research
  • Asia Market Information & Development Co.
  • Azoth Analytics
  • BioInformant
  • Black Swan Analysis
  • Canadean
  • CBR Pharma Insights
  • CRI
  • Current Analysis
  • Current Partnering
  • Daedal Research
  • Data bridge
  • Delve Insight
  • DPI Research
  • FirstWord Pharma
  • Future Market Insights
  • GBI Research
  • Global Data
  • Global Markets Direct
  • Global Research and Data Services GRDS
  • GMR Data
  • HeyReport
  • HongChun
  • HTStec
  • ICD Research
  • iGATE Research
  • IMARC
  • Industry ARC
  • Inkwood Research
  • IQ4I
  • Jain PharmaBiotech
  • Kelly Scientific
  • La Merie
  • Lifescience Intellipedia
  • LP Information
  • Market Data Forecast
  • Market Research Future
  • Marketline
  • MarketsandMarkets
  • McDerson
  • MedMarket Diligence
  • Meticulous Research
  • MicroMarketMonitor
  • MIReports
  • Mordor Intelligence LLC
  • MP Advisors
  • Occams Business Research
  • Prof Research
  • Progressive Markets
  • ProGrow Pharma Partners
  • Renub
  • Research Impact
  • RNCOS
  • Rockville Research
  • S&P Consulting
  • StratisticsMRC
  • The Business Research Company
  • Triton Market Research
  • Venture Planning Group (VPG)